# Delaware Chancery awards Nephrosant $8 million against ousted co-founder

Attorney advertising. Brief by Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. Published 2026-11-12; updated 2026-11-12. Responsible attorney: Lou Schwartz. Canonical: https://www.snalawyers.com/insights/delaware-chancery-awards-nephrosant-8-million-against-ousted-co-founde

A Delaware Court of Chancery vice chancellor issued a post-trial memorandum opinion finding that Nephrosant co-founder Minnie Sarwal concealed changes to the company's flagship kidney-transplant rejection test, destroyed company files, and courted investors for a competing venture. The court awarded Nephrosant nearly $8 million in damages on its counterclaims against Sarwal. The ruling resolves litigation that began when Sarwal sued seeking advancement and indemnification after the company's board ousted her following an internal investigation.

**Why it matters.** The decision illustrates Delaware courts' willingness to impose substantial personal monetary liability on a founder found to have concealed information and misappropriated company assets, a precedent relevant to other founder-ouster and corporate-opportunity disputes.

## Sources

1. [Chancery Hits Kidney Test Founder With $8M Judgment (law360.com)](https://www.law360.com/articles/2550068/chancery-hits-kidney-test-founder-with-8m-judgment)
2. [Delaware Courts Opinions and Orders list (courts.delaware.gov)](https://courts.delaware.gov/opinions/)

To ask the firm about this, use the intake assistant at https://www.snalawyers.com/insights/delaware-chancery-awards-nephrosant-8-million-against-ousted-co-founde#ask. General information, not legal advice.
